Title:
CD80-FC FUSION PROTEIN AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/181233
Kind Code:
A3
Abstract:
The present invention provides for CD80-Fc fusion proteins that have therapeutic and diagnostic use, and methods for making thereof. The present invention further relates to variant CD80 polypeptides. The present invention also provides for CD80-Fc fusion proteins for use in the treatment of cancer.
Inventors:
BENNETT ERIC MATTHEW (US)
ENG CHRISTINA HWEI-LIN (US)
LIN LOHSE LAURA (US)
MOSYAK LIDIA (US)
MEYERS JEREMY SHAWN (US)
SARKAR MOHOSIN (US)
YUMEREFENDI HAYRETIN RAFET (US)
ENG CHRISTINA HWEI-LIN (US)
LIN LOHSE LAURA (US)
MOSYAK LIDIA (US)
MEYERS JEREMY SHAWN (US)
SARKAR MOHOSIN (US)
YUMEREFENDI HAYRETIN RAFET (US)
Application Number:
PCT/IB2021/051865
Publication Date:
November 04, 2021
Filing Date:
March 05, 2021
Export Citation:
Assignee:
PFIZER (US)
International Classes:
C07K14/705; A61K38/00; A61P35/00; A61P37/02; C07K19/00
Domestic Patent References:
| WO2017181152A2 | 2017-10-19 | |||
| WO2019079520A2 | 2019-04-25 | |||
| WO2017151818A2 | 2017-09-08 | |||
| WO2016168771A2 | 2016-10-20 |
Attorney, Agent or Firm:
ZIELINSKI, Bryan C. (US)
Download PDF: